cyclohexanol has been researched along with Hallucination of Body Sensation in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 9 (81.82) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, JH; Chen, CH; Robson, D; Tan, HK | 1 |
| Møller, LR; Østergaard, JR | 1 |
| Ash, P; Jacob, MK | 1 |
| Gonzalez-Arriaza, HL; Krahn, LE | 1 |
| Barbiroli, B; Bernardi, F; Cicognani, A; Lin, L; Lodi, R; Mignot, E; Montagna, P; Parmeggiani, A; Plazzi, G; Posar, A; Scano, MC; Tonon, C | 1 |
| Domula, M; Felber, W; Gallinat, J; Lang, UE; Schmidt, E; Schulze, D; Stogowski, D; Tugtekin, SM | 1 |
| Cotroneo, A; Davoli, A; De Fazio, P; De Fazio, S; De Sarro, G; Gallelli, L; Gareri, P; Seminara, G | 1 |
| Blennerhassett, J; Parker, G | 1 |
| Boyd, IW | 1 |
| Abbar, M; Blayac, JP; Giniès, E; Peyrière, H; Pinzani, V; Robert, L | 1 |
| Anghelescu, I; Himmerich, H; Klawe, C; Szegedi, A | 1 |
1 review(s) available for cyclohexanol and Hallucination of Body Sensation
| Article | Year |
|---|---|
[Venlafaxine withdrawal syndrome: report of six cases and review of the literature].
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Fatigue; Female; Gastrointestinal Diseases; Hallucinations; Headache; Humans; Male; Middle Aged; Paresthesia; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Time Factors; Venlafaxine Hydrochloride | 2000 |
10 other study(ies) available for cyclohexanol and Hallucination of Body Sensation
| Article | Year |
|---|---|
Case report: Effective treatment of Cotard's syndrome: quetiapine in combination with venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cyclohexanols; Depressive Disorder; Dibenzothiazepines; Drug Therapy, Combination; Female; Hallucinations; Humans; Psychiatric Status Rating Scales; Quetiapine Fumarate; Schizophrenia, Paranoid; Syndrome; Venlafaxine Hydrochloride | 2009 |
Treatment with venlafaxine in six cases of children with narcolepsy and with cataplexy and hypnagogic hallucinations.
Topics: Cataplexy; Child; Cyclohexanols; Dose-Response Relationship, Drug; Female; Hallucinations; Humans; Male; Narcolepsy; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2009 |
Venlafaxine-induced complex visual hallucinations in a 17-year-old boy.
Topics: Adolescent; Anxiety Disorders; Cyclohexanols; Depressive Disorder, Major; Hallucinations; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2009 |
Narcolepsy with cataplexy.
Topics: Adult; Cataplexy; Comorbidity; Cyclohexanols; Hallucinations; Humans; Male; Morpholines; Narcolepsy; Patient Education as Topic; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sodium Oxybate; Venlafaxine Hydrochloride | 2004 |
Narcolepsy-cataplexy associated with precocious puberty.
Topics: Aspartic Acid; Benzhydryl Compounds; Cataplexy; Child; Creatine; Cyclohexanols; Disorders of Excessive Somnolence; Female; Hallucinations; Health Education; Humans; Hypothalamus; Intracellular Signaling Peptides and Proteins; Male; Modafinil; Narcolepsy; Neuropeptides; Night Terrors; Obesity; Orexins; Polysomnography; Puberty, Precocious; Television; Venlafaxine Hydrochloride | 2006 |
Charles Bonnet Syndrome: successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors.
Topics: Aged; Cognition; Cyclohexanols; Eye Diseases; Female; Hallucinations; Humans; Selective Serotonin Reuptake Inhibitors; Syndrome; Treatment Outcome; Venlafaxine Hydrochloride; Vision Disorders | 2007 |
Venlafaxine-propafenone interaction resulting in hallucinations and psychomotor agitation.
Topics: Aged, 80 and over; Cyclohexanols; Drug Interactions; Female; Hallucinations; Humans; Propafenone; Psychomotor Agitation; Venlafaxine Hydrochloride | 2008 |
Withdrawal reactions associated with venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hallucinations; Humans; Male; Risk Factors; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1998 |
Venlafaxine withdrawal reactions.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Depression; Depressive Disorder; Dizziness; Fatigue; Female; Hallucinations; Headache; Humans; Male; Middle Aged; Nausea; Sensation Disorders; Substance Withdrawal Syndrome; Tinnitus; Venlafaxine Hydrochloride | 1998 |
Topiramate in venlafaxine-induced visual hallucinations in an obese patient with a posterior cerebral artery infarction.
Topics: Agoraphobia; Alcoholism; Cyclohexanols; Depressive Disorder; Female; Fructose; Hallucinations; Humans; Infarction, Posterior Cerebral Artery; Middle Aged; Neuroprotective Agents; Obesity; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Topiramate; Venlafaxine Hydrochloride | 2001 |